Northbrook, IL -- (SBWIRE) -- 08/25/2021 -- The report "Dual Chamber Syringe (DCS) Filling Machine Market by Type (Automatic, Semi-Automatic And Manual), Application (Industrial Pharmacy And Hospital Pharmacy), and Region – Global Forecast To 2025" The global dual chamber syringe (DCS) filling machine market size is projected to grow from USD 258 million in 2020 to USD 381 million by 2025, at a CAGR of 8.2% between 2020 and 2025. The growth is attributed to the growing biopharmaceutical industry, increasing production of lyophilized drugs and advancement in filling machine technologies.

Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=120641941

Automatic type segment estimated to lead the dual chamber syringe (DCS) filling machine installed base market in 2019
The automatic segment accounted for the largest share in the overall dual chamber syringe (DCS) filling machine market. Automatic filling machines are used by companies with large-scale operations and high-production requirements. These types of machines are the Food and Drug Association (FDA) approved because most of the operations in automatic machines do not have human involvement, which decreases the chances of drug contamination

The industrial pharmacy estimated to be leading application of dual chamber syringe (DCS) filling machine
The industrial pharmacy led the overall dual chamber syringe (DCS) filling machine market in 2019, both in terms of value and volume. The reason for the industrial segment leading the market is it involves research, production, packaging, quality control, marketing, and sales of pharmaceutical goods. A dual chamber syringe is used for the delivery of two drugs or for the ease of use it provides with lyophilized injectable drug products. The pharmaceutical industry is looking to offer convenient products to patients for self-administration.

Speak to Analyst @ https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=120641941

APAC projected to account for the largest share of the Dual chamber syringe (DCS) filling machine installed base market during the forecast period in terms of volume.

APAC is projected to have the largest share in the global dual chamber syringe (DCS) filling machine installed base market, in terms of volume, from 2020 to 2025. The growing aging population, significant medical device manufacturing capacity, growing per capita healthcare spending, and increased health awareness in the country are driving the market in the region.

Syntegon Technologies (Germany), Prosys Servo Filling Systems (US), Dara Pharmaceutical Packaging (Spain), TurboFil Packaging Machines (US) are the key players operating in the dual chamber syringe (DCS) filling machine market. New product developments are the major strategy adopted players to enhance their positions in the dual chamber syringe (DCS) filling machine market.

COVD-19 Impact on the pharmaceutical industry supply chain
Dual chamber syringe (DCS) filling machine market is not directly impacted by the COVID 19, but disruption in supply is expected to have implications in the near future:

- COVID-19 pandemic has caused global havoc in the first half of the year, and the economic and social situation does not seem to recover till next year, at least. It has put millions of people around the world under lockdown and has killed more than 660,000 people so far. However, the pharmaceutical industry is gearing up to fight COVID-19, with rapid development for new drugs and vaccines. At the same time, the industry has suffered immense damage due to the pandemic, mainly through the disruption in the supply chain. In order to prevent the spread of the virus, various countries have gone under lockdown, which has disrupted the supply chain of the industry.
- China is one of the sources of Active Pharmaceutical Ingredients (APIs) and was also the epicenter of the COVID-19 outbreak initially. The country was put under lockdown quite early, which led to the stoppage of manufacturing and hence a decline in the export. Although China has now relaxed its restriction, there are many other countries that have implemented export control measure that has impacted the pharmaceutical supply chain
- The only positive impact of COVID-19 could be that companies will look to spread their production to different markets in order to prevent any future disruptions. According to Chemical & Engineering News, in April 2020, Senator Tom Cotton (R-AR) and Representative Mike Gallagher introduced the Protecting Our Pharmaceutical Supply Chain from China Act that calls for terminating purchases of active pharmaceutical ingredients from China by 2022. A similar trend was observed in Europe.
- As per Chemical & Engineering News, in May 2020, Evonik announced that it would invest USD 27 million to increase its active pharmaceutical ingredients production capacity at its Rosenheim and Hanau sites in Germany. The expansion has to be completed by 2021, with further expansion planned in 2024. Steps have been taken to increase the domestic supply of drug chemicals and also to reduce sourcing insecurities and overdependence on China for supply.

Get 10% Customization on this Report @ https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=120641941

About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com